Ultra-Brief Intervention to Reduce Depressive and Anxious Symptoms
Improving Access to Quality Mental Healthcare Through Innovations in Psychotherapy: A Pilot Study of a Novel, Ultra-Brief Intervention to Reduce Depressive and Anxious Symptoms
1 other identifier
interventional
25
1 country
1
Brief Summary
Symptoms of depression and anxiety are extremely prevalent in the population. Unfortunately, patients often face barriers to accessing mental health care, particularly psychotherapeutic interventions, including long wait-times and demanding therapeutic protocols. For instance, Mindfulness-Based Therapy (MBT) has demonstrated effectiveness at decreasing symptoms of depression and anxiety, and improving wellbeing; however, 'traditional' MBT can demand over 30 hours of clinical time, and 50-60 hours of homework, all of which can be barriers to care. A pilot, uncontrolled study conducted at Sunnybrook illustrated the potential feasibility / efficaciousness of a novel abbreviated MBT in improving hospital staff wellbeing. The goal of this controlled study is to further test feasibility and acceptability of this intervention to reduce depressive / anxious symptoms, reduce stress and improve wellbeing in outpatient mood/anxiety patients. If efficacious, this Abbreviated MBT could reduce barriers to accessing mental health care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable anxiety
Started Dec 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2017
CompletedFirst Posted
Study publicly available on registry
September 26, 2017
CompletedStudy Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedDecember 14, 2018
December 1, 2018
6 months
September 22, 2017
December 12, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from Baseline Depressive Symptoms at 5 Week
Scale used to measure Depressive Symptoms: Patient Health Questionnaire 9-item (PHQ-9)
Baseline (Week 0), Pre- (Week 1) and Post-Treatment Assessment (Week 5)
Change from Baseline Anxiety Symptoms at 5 Week
Scale used to measure Anxiety Symptoms: Generalized Anxiety Disorder 7-item (GAD-7)
Baseline (Week 0), Pre- (Week 1) and Post-Treatment Assessment (Week 5)
Secondary Outcomes (2)
Change from Baseline Mental Wellbeing at 5 Week
Baseline (Week 0), Pre- (Week 1) and Post-Treatment Assessment (Week 5)
Change from Baseline Self-Compassion at 5 Week
Baseline (Week 0), Pre- (Week 1) and Post-Treatment Assessment (Week 5)]
Study Arms (1)
Abbreviated Mindfulness-based Therapy
EXPERIMENTAL5 week, abbreviated group MBT treatment for depression and anxiety
Interventions
A-MBT will be delivered in group format, 120 minutes per week, for 5 consecutive weeks with 10-20 participants per group.
Eligibility Criteria
You may qualify if:
- Consenting mood and anxiety outpatients referred to Dr. Selchen in the Sunnybrook Mindfulness-Based Therapy Clinic
You may not qualify if:
- Patients who have active or recent (within 3 months) substance abuse/dependence, a history of dementia, untreated posttraumatic stress symptoms, active psychotic or manic symptoms, recent suicide attempt/active suicidality, or current self-injurious behaviour
- Previously completed a course (≥ 8 weeks) of a Mindfulness-Based Therapy within the last 3 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Selchen, MD MSt FRCPC
Sunnybrook Healthy Sciences Centre
Central Study Contacts
Steven Selchen, MD MSt FRCPC
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 22, 2017
First Posted
September 26, 2017
Study Start
December 1, 2018
Primary Completion
June 1, 2019
Study Completion
September 1, 2019
Last Updated
December 14, 2018
Record last verified: 2018-12